Geneva, May 20 -- International Clinical Trials Registry received information related to the study (NCT06961604) titled 'A Novel Method for Determination of Thromboembolic Stroke Origin' on May 6.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Atlantic Health System
Condition:
Thromboembolic Stroke
Intervention:
Drug: NaF PET-CT...
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: June 1, 2025
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06961604
Disclaimer: Curated by HT Syndication....